Publications by authors named "Bruna Brands"

Acute cannabis exposure can transiently impair cognitive performance, increasing the risk of accidental injury and potentially disrupting activities of daily living. Although sex differences in responses to cannabis have been reported, no systematic review has examined whether these extend to acute cognitive effects. Our primary aim was to examine sex differences in the acute effects of cannabis (including isolated delta-9-tetrahydrocannabinol [THC]) on cognition in humans.

View Article and Find Full Text PDF

Background: Smoked cannabis is known to have effects on cognitive function. The use of edibles is on the rise yet there are few studies of the effects of edibles on cognitive function. Further, most studies of cannabis used fixed laboratory doses which may not capture some of the nuances of more naturalistic doses.

View Article and Find Full Text PDF

Importance: Driving under the influence of cannabis increases the risk of motor vehicle collisions. In some jurisdictions, deterrence rests on the ability to detect delta-9-tetrahydrocannabinol (THC) in blood. Recent evidence suggests that there may be a nuanced relationship of blood THC to driving.

View Article and Find Full Text PDF

Introduction: Prevalence of cannabis use has historically been higher among men than among women, yet the past few decades have seen a significant narrowing of this gender gap. The narrowing gender gap is likely attributable to multiple factors, including global and regional shifts in gender norms related to cannabis, which may be influenced by legalization of recreational cannabis use in many countries, including in Canada where the present study took place. The goal of this study was to explore perceived gender norms about cannabis use and how these norms might influence behavior.

View Article and Find Full Text PDF

The COVID-19 pandemic has accelerated and amplified the use of virtual research methods. While online research has several advantages, it also provides greater opportunity for individuals to misrepresent their identities to fraudulently participate in research for financial gain. Participant deception and fraud have become a growing concern for virtual research.

View Article and Find Full Text PDF

Importance: Epidemiological studies have found that cannabis increases the risk of a motor vehicle collision. Cannabis use is increasing in older adults, but laboratory studies of the association between cannabis and driving in people aged older than 65 years are lacking.

Objective: To investigate the association between cannabis, simulated driving, and concurrent blood tetrahydrocannabinol (THC) levels in older adults.

View Article and Find Full Text PDF

Driving under the influence (DUI) of alcohol and other drugs is a common occurrence in Western societies. Alcohol consumption is related to 15% of fatal injuries in traffic accidents worldwide, with those DUI of alcohol being up to 18 times more likely to be involved in a fatal accident. Evidence for DUI of alcohol or marijuana among the college population in Mexico is scarce.

View Article and Find Full Text PDF
Article Synopsis
  • Δ9-Tetrahydrocannabinol (THC) is linked to driving impairment, but research shows mixed results about how it affects driving performance.
  • This study examined the relationship between THC levels in blood, urine, and saliva and driving behavior, specifically looking at "weaving" using a driving simulator.
  • Although no clear linear relationship between blood THC and driving impairment was found, it was observed that higher THC levels (above legal limits) in blood and saliva were associated with increased "weaving" compared to a placebo.
  • Further research is required to determine effective THC thresholds for assessing driving impairment.
View Article and Find Full Text PDF

Genetic influences on acute responses to psychoactive drugs may contribute to individual variability in addiction risk. is a human gene that encodes P-glycoprotein, an ATP-dependent efflux pump that may influence the pharmacokinetics of delta-9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. Using data from 48 young adults (aged 19-25 years) reporting 1-4 days of cannabis use per week who completed a placebo-controlled human laboratory experiment, we tested the hypothesis that the rs2235048 polymorphism of would influence acute responses to smoked cannabis.

View Article and Find Full Text PDF

Co-use of alcohol and cannabis is associated with increased frequency and intensity of use and related problems. This study examined acute effects of alcohol and cannabis on mood, subjective experience, cognition, and psychomotor performance. Twenty-eight healthy cannabis users aged 19-29 years with recent history of binge drinking completed this within-subjects, double-blind, double-dummy, placebo-controlled, randomized clinical trial.

View Article and Find Full Text PDF

The mu-opioid receptor (MOR) mediates the rewarding properties of many psychoactive drugs and is an important target in the treatment of addictions. Functional interactions between the opioid and endocannabinoid systems are established and have been hypothesized to contribute to the effects of cannabis. We investigated associations between three single nucleotide polymorphisms in the MOR gene (rs1799971, rs2281617, and rs510769) and subjective responses to smoked cannabis.

View Article and Find Full Text PDF
Article Synopsis
  • Alcohol and cannabis are the leading intoxicants found in fatal car accidents, and both increase the risk of collisions.
  • Research reviews how these substances impact simulated driving performance and their effects on breath alcohol and THC levels.
  • The study concludes that using alcohol and cannabis together worsens driving abilities, cognitive function, and alters the subjective experience of the drugs.
View Article and Find Full Text PDF

The road safety impact of cannabis has been a topic of much discussion and debate over the years. These discussions have been revitalized in recent years by initiatives in several jurisdictions to legalize non-medical cannabis. Canada became the second country to legalize non-medical cannabis use in October, 2018, preceded by Uruguay in December 2013.

View Article and Find Full Text PDF

As many jurisdictions consider relaxing cannabis legislation and usage is increasing in North America and other parts of the world, there is a need to explore the possible genetic differences underlying the subjective effects of cannabis. This pilot study investigated specific genetic variations within the cannabinoid receptor 1 () gene for association with the subjective effects of smoked cannabis. Data were obtained from a double-blinded, placebo-controlled clinical trial studying the impact of cannabis intoxication on driving performance.

View Article and Find Full Text PDF

A recent study of the impact of smoked cannabis on simulated driver behavior demonstrated a reduction in mean speed after smoked cannabis. Previous research identified an association between personality and individual differences and acute drug effects. The present study examined the impact of personality on the reduction in mean speed after smoking cannabis under single- and dual-task driving conditions originally reported by Brands et al.

View Article and Find Full Text PDF

The prevalence of co-use of alcohol and cannabis is increasing, particularly among young adults. Sex differences in the effects of alcohol alone and cannabis alone have been observed in animals and humans. However, sex differences in the acute pharmacological effects of cannabis combined with alcohol have not yet been studied.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how combined use of alcohol and cannabis affects driving performance and perception of impairment among frequent cannabis users.
  • The research involved a controlled trial where participants underwent simulated driving tests under various conditions, including combinations of the substances and placebos.
  • Results showed significant impairment in driving ability when both substances were used together, with participants often unaware of their decreased driving skills.
View Article and Find Full Text PDF
Article Synopsis
  • Critical attention to opioid prescribing has increased due to the North American opioid epidemic, particularly concerning extended release opioids which lack evidence of improved pain management.
  • In a study at a Toronto pain clinic, 61% of patients using extended release opioids took them at shorter intervals, which was linked to higher dosages and longer treatment durations, but did not result in lower pain intensity.
  • The study highlights the need for further investigation into the implications of shortened dosing intervals for patients at high risk for opioid-related harms.
View Article and Find Full Text PDF

Anxiety disorders have the highest lifetime prevalence of any mental illness worldwide, leading to high societal costs and economic burden. Current pharmacotherapies for anxiety disorders are associated with adverse effects and low efficacy. Cannabidiol (CBD) is a constituent of the plant, which has potential therapeutic properties for various indications.

View Article and Find Full Text PDF

Objectives: To examine acute and residual mood and cognitive performance in young adult regular cannabis users following smoked cannabis.

Methods: Ninety-one healthy young adults completed this double-blind, placebo-controlled, parallel-groups study. Participants were randomized to receive active (12.

View Article and Find Full Text PDF

Background: Opioids have high abuse potential and pose a major public health concern. Yet, a large percentage of individuals exposed to opioids do not develop problematic use. Individual differences in opioid abuse potential are not well understood.

View Article and Find Full Text PDF

Background: Although driving under the influence of cannabis is increasingly common among young adults, little is known about residual effects on driver behavior. This study examined acute and residual effects of smoked cannabis on simulated driving performance of young cannabis users.

Methods: In this double-blind, placebo-controlled, parallel-group randomized clinical trial, cannabis users (1-4 days/week) aged 19-25 years were randomized with a 2:1 allocation ratio to receive active (12.

View Article and Find Full Text PDF

Rationale: Animal studies have found robust sex differences in the pharmacokinetics and pharmacodynamics of Δ-tetrahydrocannabinol (THC). However, the human evidence remains equivocal, despite findings that women may experience more severe consequences of cannabis use than men.

Objectives: The objective of this secondary analysis was to examine sex differences in THC pharmacokinetics and in acute subjective, physiological, and cognitive effects of smoked cannabis in a sample of regular cannabis users (use 1-4 days per week) aged 19-25 years.

View Article and Find Full Text PDF

Introduction And Aims: While the perceived risks of driving under the influence of cannabis (DUIC) have been a focus of recent drug-driving research, relevant concepts from the social cognition literature have rarely been applied to inform understanding of DUIC. This study aims to expand knowledge of perceived collision risk and social influences associated with DUIC and driving after other substance use.

Design And Methods: Semi-structured interviews were conducted with 20 participants of a remedial program for impaired drivers.

View Article and Find Full Text PDF